The
U.S. FDA has issued a new draft guidance document: “Current Good Manufacturing
Practice—Guidance for Human Drug Compounding Outsourcing Facilities Under
Section 503B of the FD&C Act Guidance for Industry.”
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
No comments:
Post a Comment
Pharmaceutical Microbiology Resources